Related Experiment Video
Updated: Aug 21, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Impact of current treatment guidelines on minority patients with HIV infection
Valerie Stone1, Luther A Virgil
1Women's HIV/AIDS Services, Massachusetts General Hospital, Boston, Massachusetts, USA.
Insights
Updated HIV/AIDS treatment guidelines aim to improve care for adults and adolescents. Their specific benefits for minority patient populations require further investigation to ensure equitable outcomes in human immunodeficiency virus care.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Antiretroviral medicine for HIV/AIDS is complex and rapidly evolving.
- Clinical research generates substantial data, necessitating frequent guideline updates.
- The Department of Health and Human Services has issued 11 updates since April 1998.
Purpose of the Study:
- To analyze the evolution and impact of HIV/AIDS treatment guidelines.
- To assess the influence of updated antiretroviral therapy recommendations on clinical practice.
- To investigate the effectiveness of these guidelines in improving outcomes for diverse patient populations, particularly minorities.
Main Methods:
- Review of updated "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents."
- Analysis of guideline dissemination and impact on physician practice.
- Examination of clinical outcomes data, with a focus on racial and ethnic disparities.
Main Results:
- Guidelines are frequently updated to reflect advances in antiretroviral therapy.
- These guidelines influence treatment decisions for a wide range of patients.
- The impact of these guidelines on improving outcomes in minority HIV patient populations remains unclear.
Conclusions:
- Continuous updates to HIV/AIDS treatment guidelines are essential.
- Physician practice is significantly impacted by these evolving recommendations.
- Further research is needed to confirm the benefits of current HIV/AIDS guidelines for minority populations.
Abstract:
Guidelines regarding treatment of HIV/AIDS are frequently updated in response to the growing complexity of antiretroviral medicine and the volume of data emerging from clinical research. Since april 1998, the Department of Health and Human Services has issued 11 updates of its Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. These guidelines impact physician practice in the treatment of HIV-infected patients of multiple races and ethnicities, though their benefit in improving outcomes in minority patient populations is not fully understood.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

